Evidence map›Paper›PMID 40497993›Full record

ArticleCells2025

The Development and Characterisation of A Porcine Large Intestinal Biological Scaffold by Perfusion Decellularisation.

Murali Somasundaram, Karin V Greco, Gauraang Bhatnagar, Simon Gabe, Paul Sibbons, Peter Friend, Tahera Ansari

Abstract read
In one paragraph

Article in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Murali SomasundaramResearch and Development Department, Northwick Park Institute for Medical Research-The Griffin Institute, London HA1 3UJ, UK.ORCID 0009-0005-3241-857X
Karin V GrecoResearch and Development Department, Northwick Park Institute for Medical Research-The Griffin Institute, London HA1 3UJ, UK.
Gauraang BhatnagarDepartment of Radiology, St Mark's Hospital and Academic Institute, London NW10 7NS, UK.
Simon GabeLennard-Jones Intestinal Failure Unit, St Mark's Hospital and Academic Institute, London NW10 7NS, UK.
Paul SibbonsResearch and Development Department, Northwick Park Institute for Medical Research-The Griffin Institute, London HA1 3UJ, UK.
Peter FriendNuffield Department of Surgical Sciences, Oxford Transplant Centre, University of Oxford, Oxford OX1 4BH, UK.
Tahera AnsariResearch and Development Department, Northwick Park Institute for Medical Research-The Griffin Institute, London HA1 3UJ, UK.

Funding

St Mark's Small Projects Grants 28199
6 · The paper itself

Abstract

The rising incidence of colorectal cancer and ulcerative colitis underscores an urgent need for regenerative solutions to address functional deficits after colectomy. However, the creation of clinically applicable large intestine scaffolds remains underdeveloped. Here, we report the successful generation and thorough characterisation of transplantable-sized porcine large intestinal scaffolds via perfusion decellularisation. This method effectively preserved extracellular matrix (ECM) structural and biochemical integrity while minimising immunogenicity through cellular component removal. Crucially, native vasculature remained intact, confirmed by histology, DNA quantification, and high-resolution CT angiography. Despite efficient decellularisation, challenges including residual nucleic acids, ECM heterogeneity, and partial microvascular occlusion were noted, echoing ongoing limitations in engineered, perfusable, full-thickness scaffolds. In vivo implantation demonstrated favourable biocompatibility and host integration; however, thrombosis occurred due to the lack of pre-seeded cells, emphasising the necessity of recellularisation for functional perfusion prior to implantation. This study addresses significant field limitations, presenting the first reproducible approach for structurally intact, perfusable, full-thickness large intestinal scaffolds of transplantable dimensions. Our innovations offer a strong foundation for future integration of patient-derived cells, stem cells, and organoids, progressing toward clinically viable, scalable, tissue-engineered large intestine constructs, from xenogeneic sources, relevant for regenerative medicine, disease modelling, and pharmacological screening.

Indexed as

Decellularized Extracellular MatrixIntestine, LargePerfusionTissue EngineeringTissue ScaffoldsAnimalsExtracellular MatrixSwineDecellularized Extracellular Matrixfull-thickness large intestinal scaffoldsin vivoperfusable native vasculatureporcine modeltissue-engineered large intestine (TELI)xenogeneic source

Identifiers

PMID40497993
PMCPMC12155566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.